In Vivo Screening Data Summary

NCI In Vivo Screening Data

P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice

NSC 291305
CAS 1197-18-8
Tranexamic acid; DV79; DV 79

Chemical Data
Schedule (route) Endpoint Vehicle Dose Treated/Control (%) Observations
Q01DX005 (ip) median survival time saline with Tween-80 50.0 mg/kg/injection 94.0 Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5
Q01DX005 (ip) median survival time saline with Tween-80 100.0 mg/kg/injection 92.0 Antitumor endpoint evaluated on day 30; 05/05 animals surviving on day 5
Q01DX005 (ip) median survival time saline with Tween-80 200.0 mg/kg/injection 100.0 Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5
Q01DX005 (ip) median survival time saline with Tween-80 400.0 mg/kg/injection 103.0 Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5
Q01DX005 (ip) median survival time saline with Tween-80 800.0 mg/kg/injection 89.0 Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5
Q01DX009 (ip) median survival time saline with Tween-80 100.0 mg/kg/injection 99.0 Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5)
Q01DX009 (ip) median survival time saline with Tween-80 200.0 mg/kg/injection 101.0 Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5)
Q01DX009 (ip) median survival time saline with Tween-80 400.0 mg/kg/injection 100.0 Antitumor endpoint evaluated on day 30; 06/06 animals surviving on tox evaluation day (usually day 5)